To provide an overview of acquired autoimmune myasthenia gravis to affected patients, patient family and care providers in order to provide patient ability to self- advocate for appropriate treatment and management by their health care professionals and within the system of medicine and research. In addition, the conference is to provide an opportunity for networking among patients for community support and formal advocacy.